nasopharyngeal carcinoma
Conditions
Interventions
Concurrent Chemoradiotherapy Group:None
Induction Chemotherapy Combined with Concurrent Chemoradiotherapy Group:None
Radiotherapy-Only Group:None
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Pathologically confirmed nasopharyngeal carcinoma. 2. Age = 18 years. 3. Received treatment for nasopharyngeal carcinoma with complete follow-up records and clinical data available for analysis. 4. No mental illness, and no cognitive impairments affecting comprehension, expression, memory, or orientation. 5. Patients must be fully informed about the main content of the study, willing and able to participate in this prospective study, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. History of malignant tumors (excluding non-head and neck basal cell carcinoma of the skin). 2. Pregnant or lactating women. 3. Received other radiation therapy prior to radical radiotherapy for head and neck tumors (excluding cases of non-melanoma skin cancer where previous lesions were outside the target area of radiotherapy). 4. Primary and neck metastatic lesions that have previously received radiotherapy or surgical treatment (excluding diagnostic surgery). 5. Presence of other severe underlying diseases that may pose significant risks or affect compliance with the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor regression before and after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in EBV DNA levels during treatment; | — |
Countries
China
Contacts
Public ContactSun Ying
Sun Yat-sen University Cancer Center
Outcome results
None listed